386 related articles for article (PubMed ID: 24178906)
21. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.
Konstan MW; Morgan WJ; Butler SM; Pasta DJ; Craib ML; Silva SJ; Stokes DC; Wohl ME; Wagener JS; Regelmann WE; Johnson CA;
J Pediatr; 2007 Aug; 151(2):134-9, 139.e1. PubMed ID: 17643762
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for lung function decline in a large cohort of young cystic fibrosis patients.
Cogen J; Emerson J; Sanders DB; Ren C; Schechter MS; Gibson RL; Morgan W; Rosenfeld M;
Pediatr Pulmonol; 2015 Aug; 50(8):763-70. PubMed ID: 26061914
[TBL] [Abstract][Full Text] [Related]
23. Association between genetically determined pancreatic status and lung disease in adult cystic fibrosis patients.
Loubières Y; Grenet D; Simon-Bouy B; Medioni J; Landais P; Férec C; Stern M
Chest; 2002 Jan; 121(1):73-80. PubMed ID: 11796434
[TBL] [Abstract][Full Text] [Related]
24. A systematic review of studies examining the rate of lung function decline in patients with cystic fibrosis.
Harun SN; Wainwright C; Klein K; Hennig S
Paediatr Respir Rev; 2016 Sep; 20():55-66. PubMed ID: 27259460
[TBL] [Abstract][Full Text] [Related]
25. Lung function from infancy to the preschool years after clinical diagnosis of cystic fibrosis.
Kozlowska WJ; Bush A; Wade A; Aurora P; Carr SB; Castle RA; Hoo AF; Lum S; Price J; Ranganathan S; Saunders C; Stanojevic S; Stroobant J; Wallis C; Stocks J;
Am J Respir Crit Care Med; 2008 Jul; 178(1):42-9. PubMed ID: 18403721
[TBL] [Abstract][Full Text] [Related]
26. Longitudinal growth and lung function in pediatric non-cystic fibrosis bronchiectasis: what influences lung function stability?
Kapur N; Masters IB; Chang AB
Chest; 2010 Jul; 138(1):158-64. PubMed ID: 20173055
[TBL] [Abstract][Full Text] [Related]
27. Pulmonary abnormalities on high-resolution CT demonstrate more rapid decline than FEV1 in adults with cystic fibrosis.
Judge EP; Dodd JD; Masterson JB; Gallagher CG
Chest; 2006 Nov; 130(5):1424-32. PubMed ID: 17099020
[TBL] [Abstract][Full Text] [Related]
28. Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis.
Dasenbrook EC; Merlo CA; Diener-West M; Lechtzin N; Boyle MP
Am J Respir Crit Care Med; 2008 Oct; 178(8):814-21. PubMed ID: 18669817
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for lung disease progression in children with cystic fibrosis.
van Horck M; van de Kant K; Winkens B; Wesseling G; Gulmans V; Hendriks H; van der Grinten C; Jöbsis Q; Dompeling E
Eur Respir J; 2018 Jun; 51(6):. PubMed ID: 29773689
[TBL] [Abstract][Full Text] [Related]
30. Early respiratory infection is associated with reduced spirometry in children with cystic fibrosis.
Ramsey KA; Ranganathan S; Park J; Skoric B; Adams AM; Simpson SJ; Robins-Browne RM; Franklin PJ; de Klerk NH; Sly PD; Stick SM; Hall GL;
Am J Respir Crit Care Med; 2014 Nov; 190(10):1111-6. PubMed ID: 25321321
[TBL] [Abstract][Full Text] [Related]
31. The effect of early Pseudomonas aeruginosa treatment on lung function in pediatric cystic fibrosis.
Amin R; Lam M; Dupuis A; Ratjen F
Pediatr Pulmonol; 2011 Jun; 46(6):554-8. PubMed ID: 21337727
[TBL] [Abstract][Full Text] [Related]
32. Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis.
Corey M; Edwards L; Levison H; Knowles M
J Pediatr; 1997 Dec; 131(6):809-14. PubMed ID: 9427882
[TBL] [Abstract][Full Text] [Related]
33. Reduced survival in adult cystic fibrosis despite attenuated lung function decline.
Keating C; Poor AD; Liu X; Chiuzan C; Backenroth D; Zhang Y; DiMango E
J Cyst Fibros; 2017 Jan; 16(1):78-84. PubMed ID: 27522311
[TBL] [Abstract][Full Text] [Related]
34. Improving rate of decline of FEV1 in young adults with cystic fibrosis.
Que C; Cullinan P; Geddes D
Thorax; 2006 Feb; 61(2):155-7. PubMed ID: 16384880
[TBL] [Abstract][Full Text] [Related]
35. Variation in lung function is associated with worse clinical outcomes in cystic fibrosis.
Heinzmann-Filho JP; Pinto LA; Marostica PJ; Donadio MV
J Bras Pneumol; 2015; 41(6):509-15. PubMed ID: 26785959
[TBL] [Abstract][Full Text] [Related]
36. [Pancreatic infringement exocrine and endocrine in cystic fibrosis].
Kessler L; Abély M
Arch Pediatr; 2016 Dec; 23(12S):12S21-12S32. PubMed ID: 28231890
[TBL] [Abstract][Full Text] [Related]
37. Incident Stenotrophomonas maltophilia infection and lung function decline in cystic fibrosis.
Barsky EE; Williams KA; Priebe GP; Sawicki GS
Pediatr Pulmonol; 2017 Oct; 52(10):1276-1282. PubMed ID: 28815999
[TBL] [Abstract][Full Text] [Related]
38. Sex disparities in effects of cystic fibrosis-related diabetes on clinical outcomes: a matched study.
Miller RJ; Tildesley HD; Wilcox PG; Zhang H; Kreisman SH
Can Respir J; 2008 Sep; 15(6):291-4. PubMed ID: 18818782
[TBL] [Abstract][Full Text] [Related]
39. Effect of allergic bronchopulmonary aspergillosis on FEV
Kaditis AG; Miligkos M; Bossi A; Colombo C; Hatziagorou E; Kashirskaya N; de Monestrol I; Thomas M; Mei-Zahav M; Chrousos G; Zolin A
Arch Dis Child; 2017 Aug; 102(8):742-747. PubMed ID: 28325727
[TBL] [Abstract][Full Text] [Related]
40. Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.
Saiman L; Anstead M; Mayer-Hamblett N; Lands LC; Kloster M; Hocevar-Trnka J; Goss CH; Rose LM; Burns JL; Marshall BC; Ratjen F;
JAMA; 2010 May; 303(17):1707-15. PubMed ID: 20442386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
